The study is designed to provide drug company decision makers, drug delivery developers, device designers, healthcare marketers, and supply chain participants with a detailed understanding of the economics, technologies, participants and commercial opportunities within the autoinjector segment of the prefilled syringe market. Provider organization business managers, healthcare administrators and investors will also benefit from this study.
Syringes that can be prefilled on standard fill-and-finish lines have had a dramatic effect on the way injectable drugs are developed, prescribed and administered. This impact has been accelerated by the introduction and evolution of autoinjectors - devices that are designed to accept a standard prefilled syringe and form an outer user-friendly device package that simplifies the injection process. While autoinjectors are sometimes designed to work with a particular injectable product as a form of pharmaceutical branding, the typical autoinjector is designed to fit one or more standard sizes of prefilled disposable syringes. Autoinjectors enable a significantly larger segment of the patient population to self-administer injectables. This report analyzes eleven important therapeutic segments and examines the impact of autoinjectors on injectable drug markets.